Filter Articles
2018 Research Grant Finalists Announced
Research is critical to serving the cause and the community. The GBS-CIDP Foundation International believes…
FDA approves CSL Behring treatment for CIDP
The Food and Drug Administration granted marketing clearance Friday for Hizentra, a treatment for chronic inflammatory demyelinating…
2017 GBS|CIDP Foundation Grant Awardees
(#1) Title of the project: Enhance Peripheral Nerve Repair by Modulating Macrophage Subsets Investigator: Gang Zhang, M.D;…
Research Published on Quality of Life in Inflammatory Neuropathies: the IN-Qol
In 2008 the GBS|CIDP Foundation awarded a $60,000 to Ingemar S. J. Merkies, MD, PHD…
Hansa Medical receives FDA Orphan Drug Designation for IdeS and the treatment of Guillain-Barré syndrome
February 16, 2018 Hansa Medical today announced that the U.S. Food and Drug Administration (FDA)…
Interlaken Leadership Awards
The Interlaken Leadership Awards support original research in the field of neuroimmunology. Investigators whose proposals…
Towards an affordable treatment of GBS for patients from low-income countries
Guillain-Barré syndrome (GBS) takes its toll on the resource poor developing countries where the incidence…
A dose-response trial of IV immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)/DRIP study
K. Kuitwaard1,2, E Brusse1, A.F.J.E. Vrancken4, F. Eftimov5, N.C. Notermans4, A.J. van der Kooi5, I.S.J.…
The PATH Study
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20) The PATH Study was…
Japanese Ecuilizumab Trial for GBS
A new treatment with compliment inhibition improves motor function in Guillain- Barré syndrome: Japanese eculizumab…
IMAGiNe study
IgM paraprotein associated polyneuropathy is a slowly progressive disease with numbness or tingling of arms…
Announcing the 2017 GBS|CIDP Foundation Grant Awardees
2017 GBS|CIDP Foundation Grant Awardees (#1) Title of the project: Enhance Peripheral Nerve Repair by Modulating Macrophage…
GBS|CIDP Foundation International 2017 Benson Clinical Research Fellowship
GBS|CIDP Foundation International 2017 Benson Clinical Research Fellowship The GBS|CIDP Foundation International is pleased to…
Largest Ever CIDP Clinical Study Completed
Largest Ever CIDP Clinical Study Completed PATH study evaluated subcutaneous immunoglobulin efficacy and safety for…
Incidence of Guillain-Barré Syndrome Rising As Zika Spreads
Dr. Ken Gorson Dr. Kenneth C. Gorson, MDPresident Elect GBS|CIDP Foundation International Global Medical Advisory…